ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy
Jian Kong(Beijing Chao-Yang Hospital), Lemin Zheng(Capital Medical University)
Cited by 31
Related Papers
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
|Journal of Clinical Investigation|2004|647
Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA
|PLoS ONE|2012|130
Diabetic HDL Is Dysfunctional in Stimulating Endothelial Cell Migration and Proliferation Due to Down Regulation of SR-BI Expression
|PLoS ONE|2012|47
Annexin A1 binds PDZ and LIM domain 7 to inhibit adipogenesis and prevent obesity
|Signal Transduction and Targeted Therapy|2024|14